Pretreatment with PQDS significantly increased the expression of Bcl-2 compared with that in the MCAO group, suggesting that PQDS may mediate the protective effect against cerebral ischemia by inhibiting apoptosis. The gene discussed is BCL2; the disease is brain ischemia.